The average stock on the S&P 500 yields just 1.3%. That's a modest return on your money, but that's only the average. There are many dividend stocks that pay you much more than that. While you don't necessarily want to go for double-digit yields (which involve stocks that tend to be extremely risky), you can find plenty of safe, high-yielding stocks to own and hang on to for the long haul. Fast-food restaurants are facing challenges amid rising prices and consumers using GLP-1 weight loss drugs, which can c ...

Elevance Health, Inc. (ELV) uses AI for predictive analytics to identify high-risk members and tailor treatment plans based on clinical and genetic data. Elevance's AI-powered chatbots assist customers, while fraud detection and care coordination tools enhance operations. The Health OS platform and smart claims engine streamline processes, improve accuracy and reduce Elevance's training time. UnitedHealth's Price Performance, Valuation and Estimates Shares of UNH have lost 40.6% in the year-to-date period c ...

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc. Investors have until July 11, 2025, to ask the Court to be appointed t ...

Blue chip stocks possess several important attributes. The businesses behind the stocks are large and financially strong and usually leaders in their markets. They also have a reputation for dependability. The company suspended its full-year 2025 guidance, mainly because of higher-than-anticipated Medicare Advantage costs, and its former CEO Andrew Witty unexpectedly stepped down. The Wall Street Journal reported that the U.S. Department of Justice has launched a criminal investigation into UnitedHealth Gro ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elevance To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $100,000 in Elevance between April 18, 2024 and October 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, June 20, 2025 /PRNewsw ...

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc. Investors have until July 11, 2025, to ask the Court to be appointed t ...

I am bullish on (NYSE: UNH ), driven by the company’s diversified model seen in an impressive FY2024 growth outlook of between $450 billion and $455 billion for FY2025. Despite projected federal Medicaid budget cutsFirst Principles Partners is an equity research analyst specializing in technology, innovation, and sustainability investment. My unique approach, "First Principles," involves breaking down complex problems to their most basic elements in terms of financial and technology, enabling me to uncover ...

If you're seeking dividend income, bravo -- because dividends are hard to beat. Healthy and growing dividend-paying stocks will keep sending you cash, no matter whether the economy is booming or slumping. And that cash is handy not only for retirees. Younger investors can use it to just buy more shares of stock. One dividend payer to consider is UnitedHealth Group (UNH -0.64%), with a 2.8% dividend yield. Imagine you're seeking $1,000 in annual income from UnitedHealth stock. How many shares must you buy?We ...

I first initiated a "Buy" rating on Oscar Health (NYSE: OSCR ) in March 2025 here . Since then, the stock has fallen down to $12, only then to climb back up to the $16 range where we areMMMT Wealth is run by Oliver, a CPA working in the financial services sector mainly in private equity, hedge funds, and asset management. MMMT Wealth began in 2023 when Oliver started writing online mainly on X and Substack about investment strategies and stocks. His main aim is to gather insights from investor calls, presen ...

Core Insights - The healthcare sector is significantly influenced by major players like UnitedHealth Group and CVS Health, both of which integrate insurance and care delivery [1][2] - UnitedHealth's recent challenges include rising medical costs and regulatory shifts, while CVS is seen as a strong value play with a clear turnaround strategy [2] UnitedHealth Group (UNH) - UNH reported first-quarter revenues of $109.6 billion and adjusted net income of $6.6 billion, maintaining a 6% net margin [3] - The company missed earnings estimates once in the past four quarters, with an average surprise of 1.2% [4] - Medical costs surged 11.7% in the first quarter, following a 9.2% rise in 2024, with expectations of over 16% growth in 2025 [5] - UNH's pharmacy benefit manager, Optum Rx, may face regulatory challenges affecting pricing power [6] - The new CEO, Steve Hemsley, has pledged to rebuild shareholder trust after the company's first earnings miss in nearly two decades [7] CVS Health Corporation (CVS) - CVS reported first-quarter revenues of $94.6 billion and net income of $1.8 billion, with adjusted EPS of $2.25, beating last year's $1.31 by 31.6% [8][10] - The Health Care Benefits segment's medical benefit ratio improved to 87.3%, reflecting better cost control [8] - CVS has consistently beaten earnings estimates in the past four quarters, with an average surprise of 18.1% [9] - The company raised its 2025 EPS guidance to $6.00-$6.20, up from $5.75-$6.00, and anticipates $500 million in savings from retail store closures [10][14] - CVS's diversified model is showing momentum with rising retail script volumes and improved operating income across segments [12] Comparative Analysis - Zacks Consensus Estimates favor CVS, with upward revisions in EPS estimates, while UNH has seen multiple downward revisions [15] - CVS trades at a forward P/E of 10.31, compared to UNH's 12.98, indicating a more attractive risk-reward profile for CVS [16] - Year-to-date, UNH shares have dropped 39% due to medical cost concerns, while CVS shares have increased by 49.4% [18] Conclusion - UnitedHealth faces challenges with cost control and guidance uncertainties, while CVS is executing a successful turnaround with improving margins and positive analyst sentiment [21][22] - For investors seeking upside potential, CVS Health is positioned as the stronger investment option in the current healthcare landscape [22]